Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
2 Takeda lays out $126M to tap robotics, virtual reality and more at California production site
3 Takeda expansion is latest coup for Conejo Valley pharma industry
4 Takeda agrees to supply additional 50 million Moderna COVID-19 vaccines to Japan
5 How Takeda is thinking about value-based arrangements with payers
6 With Takhzyro durability data, Takeda tries to fend off BioCryst's hereditary angioedema challenger Orladeyo
7 Where Do Hedge Funds Stand On Takeda Pharmaceutical Company Limited (TAK)?
8 Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange
9 Takeda, Endo reaped 'many hundreds of millions' through Amitiza pay-for-delay deal, lawsuit claims
10 XBIO Stock: Xenetic Soars on Takeda Expansion News
11 Rady Children’s Teams with Takeda Pharmaceutical to Develop New Treatments
12 Takeda promotes empathy for IBD patients with immersive 'In Their Shoes' experience
13 Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
14 Takeda reports new data from late-stage Takhzyro study in HAE at EAACI hybrid congress
15 Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma's July price hikes: report
16 Takeda Pharmaceutical, Rady Children's Partner on Rare Genetic Disease Drug Development
17 Vivid Botanicals Bloom from the Coats of Charismatic Cats in Watercolor Works by Hiroki Takeda
18 Takeda chief Christophe Weber talks about his younger days
19 A Deep Research on Takeda Pharmaceutical Company Limited (TAK) Stock
20 Moderna Partners with Takeda and Govt. of Japan for 50M Vaccine Doses
21 Class-action accuses Takeda of 'pay-for-delay' deal with Par
22 Ufuoma Ovienmhada selected for Takeda Fellowship — MIT Media Lab
23 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor
24 Takeda Korea marks 10th anniversary with plans for next decade
25 Not Throwing In The Towel: Takeda Pharmaceutical Company Limited (TAK), Grifols S.A. (GRFS)
26 Takeda India brings diagnostic program in support of rare diseases
27 New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid C
28 EXECUTIVE CHANGES: Croda taps Takeda exec; Bidstack brings in ex-EA
29 Takeda's ulcerative colitis drug shows excellent efficacy, safety in Asian patients
30 Takeda and Endo hit with pay-for-delay claims
31 Constipation Treatment Market Size, Growth (2021-2028) | Top Key Vendors – Takeda Pharmaceutical Company Ltd., Synergy Pharmaceuticals, Abbott Laboratories, AstraZeneca, Bayer AG, – The Manomet Current
32 Insights on Microbiome Targeted Therapeutics in Immunology 2021 Report
33 Peptide Therapeutics Market Size, CAGR | Key Players – Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca – The Manomet Current
34 Takeda, Endo Face Antitrust Suit Over Constipation Drug Amitiza
35 Artist Combines Animals With Flowers in Colorful Watercolor Paintings
36 Takeda Pharmaceutical Co Ltd (TAK): Price Now Near $16.83; Daily Chart Shows Downtrend on 100 Day Basis
37 Is Xenetic Biosciences (XBIO) Stock All Set To Hit $5 This Week?
38 #OlympicDucks Guide: July 20-25
39 Global Primary Progressive Multiple Sclerosis (PPMS) Market Report Forecast to 2021-2027 |key players are Sanofi, Biogen, Mapi Pharma, MediciNova, AB Science, Takeda, Atara Biotherapeutics, and many others. – The Manomet Current
40 Turnstone Biologics Raises $80 Million Series D Financing
41 Prurigo Nodularis Treatment Market Size, Growth (2021-2028) | Top Key Vendors – Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc. – The Mano
42 Takeda to Acquire Maverick Therapeutics for up to $525 Million
43 Takeda Accused of Favoring Japanese Patients for Cancer Drug
44 Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
45 Pharmaceutical Drug Market Future Trends Landscape 2027| GSK, AbbVie, Eli Lilly, Takeda, Pfizer Inc. Johnson and Johnson – The Manomet Current
46 Dicerna's RNA-silencing drug curbs harmful protein in rare liver disease
47 Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio
48 Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone
49 Takeda Pharmaceutical reports decline in FY2020 revenue
50 Market Opportunities for Hypertension Drugs Industry by Daiichi Sankyo Co. Ltd., Takeda Pharmaceutical Co. Ltd., United Therapeutics Corp., AstraZeneca plc, Valeant Pharmaceuticals International Inc., Actelion Ltd, and more | Affluence – Murphy's Hoc
51 Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
52 Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
53 Clarithromycin Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Abbvie, Abbott, Takeda Pharms, West-Ward Pharms, Actavis Labs Fl Inc, Sun Pharm Inds, Mylan, Mayn… – Jumbo News
54 Takeda Is A Mediocre Income Investment
55 Rheumatology Drugs Market SWOT Analysis, Business Growth Opportunities By Top Companies: Takeda Pharmaceutical, Sanofi, Genentech, etc. – Murphy's Hockey Law
56 Clarithromycin Market Projected to Show Strong Growth 2027 | Abbvie, Abbott, Takeda Pharms, West-Ward Pharms, Actavis Labs Fl Inc – The Manomet Current
57 Global K Cells Market Research Study 2021 Key Companies Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (USA), NantKwest Inc. (USA), Bristol Myers Squibb (USA), NKT Therapeutics (USA) – Murphy's Hockey Law
58 Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan
59 Sexual Dysfunction Drugs Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Pfizer, Takeda, Eli Lilly, GlaxoSmithKline, Teva Pharmaceutical Industries, Merck, Emot… – Murphy's Hockey Law
60 Human Alpha1-Proteinase Inhibitor Market to Witness Steady Expansion During 2021 – 2027 | Takeda, Kamada, Talecris Biotherapeutics, CSL Behring, – NeighborWebSJ
61 Global Sleeping Aids Market : Industry Trends SWOT Analysis by Top Companies – Takeda Pharmaceutical Company, CareFusion Corporation – The Manomet Current
62 Ophthalmology Drugs Market by Major Players| Allergan, Santen Pharmaceutical, Genentech, Bayer, Takeda, and More… – The Manomet Current
63 Takeda Hosts Wave 1 Pipeline Market Call Business Wire • 04-01-2021
64 Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
65 Proteasome Inhibitors Market Technology, Recent Trends, Future Growth Analysis Forecasts 2027 | Johnson & Johnson, Takeda Pharmaceutical – The Manomet Current
66 Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
67 Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
68 Clarithromycin Tablets Market Size, Forecast, and Key Manufacturers – Abbvie, Abbott, Mylan, Apotex, Sandoz, Takeda Pharmaceuticals – The Manomet Current
69 BFS (Blow-Fill-Seal) Products Market Size, Current and Future | Nephron Pharmaceuticals, Takeda Pharmaceuticals, Recipharm, TRC, SIFI
70 Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
71 Gas Turbine Generators Market Booming Worldwide with Latest Trend and Future Scope by 2027 | Takeda pharmaceutical, Valeant Pharmaceuticals International Inc., Janssen Biotech Inc., Bayer AG
72 Takeda bets on Japan R&D hub for next blockbuster drug
73 Generic Drug Market To Lift Up Industry Growth During The Forecast Period From 2020 – 2027, Key Players – Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Takeda Pharmaceutical Company Ltd. – The Manomet Current
74 Rheumatology Drugs Market 2021 also Industry is Booming Worldwide with Key Players | Takeda Pharmaceutical, Sanofi, Genentech, etc. – NeighborWebSJ
75 Takeda Completes Sale of Select Non-Core Assets to Cheplapharm
76 Muscle Relaxers Market 2021-2026 Global Analysis by Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Takeda Pharmaceutical, and more | Affluence – Murphy's Hockey Law
77 Takeda struggles to deliver returns from massive Shire deal
78 With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO
79 Depression is complex. It took time to find my voice.
80 Anima signs new strategic collaboration deal with Takeda
81 Takeda and IDT Biologika to Manufacture J&J's COVID-19 Vaccine
82 Takeda's Growth and Emerging Markets Business Unit Aims to Deliver Double-Digit Revenue Growth Over Next Decade1
83 Takeda Named Global Top Employer for Fourth Consecutive Year
84 Dry Eye Disease Market Share Growth, Size Value, Trends, Rigonal outlook by 2037 | Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical – The Manomet Current
85 Takeda says it may double imports of Moderna shots to help accelerate Japan vaccination
86 Takeda takes full control of drug for rare epilepsies
87 Natpara at 100 mcg Dose in Short Supply for Hypoparathyroidism: Takeda
88 Takeda to expand cell therapy facility in Ireland
89 Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push
90 UPDATED: 2400 people remain without rare disease drug as Takeda manufacturing woes continue
91 Takeda's rare disease med Natpara faces long road back to market as manufacturing issues multiply
92 Oral Hypoglycemic Drugs Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Pfizer, Takeda Pharmaceuticals, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson,… – Jumbo News
93 Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone
94 Takeda offloads heart and metabolism drugs to 3-month-old Chinese firm for $322M
95 Takeda: A Rare Biopharma Bargain
96 Etanercept Market 2021-2027 Growth Analysis, Business Opportunities And Segmentation with Top Key Players: Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz – The Manomet Current
97 Insomnia Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, … – Jumbo News
98 Takeda's Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade
99 Takeda Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd. (Fed. Cir. 2021)
100 Bleeding Disorders Treatment Market Analysis of Key Trends, Industry Dynamics and Future Growth 2021 | Takeda, Bayer, Biogen, CSL Behring – NeighborWebSJ